Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  Yunnan Baiyao Group Co.,Ltd    000538   CNE0000008X7

YUNNAN BAIYAO GROUP CO.,LTD

(000538)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
01/22/2021 01/25/2021 01/26/2021 01/27/2021 01/28/2021 Date
138.75 139.39 133.38 135.45 132 Last
9637860 11209520 8374698 8512068 5332847 Volume
+1.48% +0.46% -4.31% +1.55% -2.55% Change
Financials
Sales 2020 32 724 M 5 059 M 5 059 M
Net income 2020 4 641 M 717 M 717 M
Net cash position 2020 19 185 M 2 966 M 2 966 M
P/E ratio 2020 35,9x
Yield 2020 1,75%
Sales 2021 36 016 M 5 567 M 5 567 M
Net income 2021 5 143 M 795 M 795 M
Net cash position 2021 20 882 M 3 228 M 3 228 M
P/E ratio 2021 32,4x
Yield 2021 1,95%
Capitalization 168 B 25 957 M 26 011 M
EV / Sales 2020 4,56x
EV / Sales 2021 4,09x
Nbr of Employees 8 124
Free-Float 33,3%
More Financials
Company
Yunnan Baiyao Group Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical products. The group proposes primarily traditional medicine products, phytobiological products, body care products, antibiotics and anti-inflammatory. China accounts for 97.8% of net sales. 
More about the company
Notations Surperformance© of Yunnan Baiyao Group Co.,Ltd
Trading Rating : Investor Rating :
More Ratings
All news about YUNNAN BAIYAO GROUP CO.,LTD
2020Yunnan Baiyao Holds Off Share Buyback for Fourth Month in October
MT
2020YUNNAN BAIYAO GROUP CO.,LTD : annual earnings release
2018Trade war or not, China Inc already reining in American brands
RE
2014China brands beat global rivals with tea toothpaste & pickled plums
RE
More news
News in other languages on YUNNAN BAIYAO GROUP CO.,LTD
2020YUNNAN BAIYAO GROUP CO.,LTD : publication des résultats annuels
2020YUNNAN BAIYAO GROUP CO.,LTD : Veröffentlichung des Jahresergebnisses
More news
Chart YUNNAN BAIYAO GROUP CO.,LTD
Duration : Period :
Yunnan Baiyao Group Co.,Ltd Technical Analysis Chart | 000538 | CNE0000008X7 | MarketScreener
Technical analysis trends YUNNAN BAIYAO GROUP CO.,LTD
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 12
Average target price 130,95 CNY
Last Close Price 132,00 CNY
Spread / Highest target 19,7%
Spread / Average Target -0,79%
Spread / Lowest Target -24,1%
EPS Revisions
Managers and Directors
NameTitle
Ming Hui Wang Chairman & Chief Executive Officer
Guang Hui You Chairman-Supervisory Board
Fa Shu Chen Co-Chairman
Wei Wu Chief Financial Officer, Secretary & Senior VP
Chang Hong Yang Director
Sector and Competitors
1st jan.Capitalization (M$)
YUNNAN BAIYAO GROUP CO.,LTD16.20%26 635
JOHNSON & JOHNSON6.67%441 951
ROCHE HOLDING AG3.62%309 011
NOVARTIS AG0.20%212 810
PFIZER INC.-1.55%201 436
MERCK & CO., INC.-5.78%194 990